| 1 |  | AZINOL-250 (BL-MONO) | 6'S | EACH FILM COATED TABLET CONTAINS: AZITHROMYCIN 250MG, (COLOUR YELLOW OXIDE OF IRON), EXCIPIENTS Q.S, |
| 2 |  | AZINOL-500 TAB (BL-MONO) | 3'S | EACH FILM COATED TABLET CONTAINS: AZITHROMYCIN DIHYDRATE EQ. TO AZITHROMYCIN ANHYDROUS 500MG, EXCIPIENTS Q.S, COLOUR TITANIUM DIOXIDE & YELLOW OXIDE OF IRON |
| 4 |  | LINZONOL-600 TAB (STRIP) | 4'S | EACH FILM COATED TABLET CONTAINS: LINZOLID IP 600MG, EXCIPIENTS Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 5 |  | OFOXO® -CF TAB (ALU) | 10'S | EACH FILM COATED TABLET CONTAINS: CEFIXIME I.P. EQ. TO ANHYDROUS CEFIXIME 200MG, OFLOXACIN I.P. 200MG, COLOUR: LAKE QUINOLINE YELLOW |
| 6 |  | QUARTUM® 500 TAB (MONO) | 4'S | EACH FILM COATED TABLET CONTAINS: CEFUROXIME AEXITIL 500MG. |
| 7 |  | CLINDANOL-300 CAP (BL) | 10,S | EACH HARD GELATIN CAPSULE CONTAINS: CLINDAMYCIN HCL IP 300MG, EXCIPIENTS, APPROVAL COLOUR USED IN CAPSULE SHELLS. |
| 8 |  | MOXIN-250 CAP (R/W) 30'S | 10'S | EACH HARD GELATIN CAPSULE CONTAINS: AMOXYCILLIN 250MG, EXCIPIENTS Q.S, |
| 9 |  | MOXIN-500 CAP (ORANGE) 10'S | 10'S | EACH HARD GELATIN CAPSULE CONTAINS: AMOXYCILLIN 500MG, EXCIPIENTS Q.S, |
| 10 |  | MOXINCLAV-IV INJ 1.2GM | 1.2GM | EACH VIAL CONTAINS: STERILE AMOXYCILLIN SODIUM I.P. EQ. TO AMOXYCILLIN 1GM, STERLIE POTASSIUM CLAVULANATE I.P. EQ. TO CLAVULANIC ACID 200MG, |
| 12 |  | OFOXO® SUSP 30ML | 30ML | EACH 5ML CONTAINS: OFLOXACIN 50MG, IN A FLAVOURED SYRUP BASE Q.S, |
| 13 |  | OFOXO® SUSP 60ML | 60ML | EACH 5ML CONTAINS: OFLOXACIN 50MG, IN A FLAVOURED SYRUP BASE Q.S, |
| 15 |  | CEFAXIME-O DS DRY SYP | 30ML | EACH 5ML OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME IP EQ. TO CEFAXIME ANHYDROUS 100MG, EXCIPIENTS Q.S, IN A FLAVOURED SYRUP BASE Q.S, COLOUR: QUINOLINE YELLOW [J02129] |
| 16 |  | KAXIM DRY SYP 30ML | 30ML | EACH 5ML OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME IP 50MG, EXCIPIENTS Q.S. IN A FLAVOURED SYRUP BASE COLOUR: SUNSET YELLOW FCF |
| 17 | | CEFROZONE-S® 1.5GM INJ | 1.5GM | EACH VIAL CONTAINS: CEFOPERAZONE SODIUM IP 1000MG, SULBACTUM SOUDIM USP 500MG, EXCIPIENTS Q.S, |
| 18 |  | CEFROZONE-S® 1GM INJ | 1GM | EACH VIAL CONTAINS: CEFOPERAZONE SODIUM IP 500MG, SULBACTUM SOUDIM USP 500MG, EXCIPIENTS Q.S, |
| 19 |  | CLINDANOL 2ML INJ. | 2ML | EACH ML CONTAINS: CLINDAMYCIN PHOSPHATE IP EQ. TO CLINDAMYCIN 150MG, BENZYL ALCOHOL I.P (AS PRESERVATIVE) 1.5%V/V,WATER FOR INJECTION IP Q.S, |
| 20 |  | CLINDANOL 4ML INJ. | 4ML | EACH ML CONTAINS: CLINDAMYCIN PHOSPHATE IP EQ. CLINDAMYCIN 150MG, BENZYL ALCOHOL I.P (AS PRESERVATIVE) 1.5% V/V, WATER FOR INJECTION IP Q.S, |
| 21 |  | MIRAJ INJ 1GM | 1GM | EACH VIAL CONTAINS: MEROPENEM 1GM, SODIUM 86MG, EXCIPIENTS Q.S, |
| 22 |  | MIRAJ INJ 500MG | 500MG | EACH VIAL CONTAINS: STERILE MEROPENEM TRIHYDRATE IP, EQ. TO ANHY. MEROPENEM 500MG, ALSO CONTAINS: STERILE SODIUM CARBONATE (SODIUM 45.1MG)
|
| 23 |  | MIRAJ-S 1.5GM INJ | 1.5GM | EACH VIAL CONTAINS: STERILE MEROPENEM IP EQ. TO ANHYDROUS MEROPENEM 1000MG, ALSO CONTAINS STERILE SODIUM CARBONATE IP (SODIUM 90.2 MG) ADDED AS BUFFER STERILE SULBACTAM SODIUM USP EQ. TO SULBACTAM 500MG, |
| 24 |  | PIPRATAC® - INJ 4.5 GM | 4.5GM | EACH VIAL CONTAINS: STERILE PIPERACILLIN SODIUM USP EQ. TO PIPERACILLIN 4000MG, STERILE TAZOBACTAM SODIUM EQ. TO TAZOBACTAM 500MG, |
| 25 |  | QUARTUM® -1.5GM INJ | 1.5GM | EACH VIAL CONTAINS: CEFUROXIME SODIUM I.P (STERILE) EQ. TO CEFUROXIME 1500 MG, |
| 26 |  | QUARTUM® -750 INJ | 750MG | EACH VIAL CONTAINS: CEFUROXIME 750MG |
| 27 |  | CEFAXIME-CL TAB (STRIP-MONO) | 6'S | EACH FILM COATED TABLET CONTAINS: CEFIXIME 200MG, CLAVULANIC ACID 125MG, EXCIPIENTS Q.S, |
| 28 |  | CEFAXIME-O 200DT TAB (ALU) | 10'S | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: CEFIXIME TRIHYDRATE IP EQ. TO CEFIXIME (ANHYDROUS) 200MG, EXCIPIENTS Q.S, |
| 29 | | CEFAXIME-O 200DT TAB (MONO-ALU) | 10'S | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: CEFIXIME IP (AS TRIHYDRATE) EQ. TO ANHYDROUS CEFIXIME 200MG, EXCIPIENTS Q.S, |
| 30 |  | C-FODE-100 TAB (MONO-ALU) | 10'S | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: CEFPODOXIME PROXETIL EQ. TO CEFPODOXIME IP 100MG, COLOUR TITANIUM DIOXIDE IP |
| 31 |  | C-FODE-200 TAB (MONO-ALU) | 10'S | EACH FILM COATED TABLET CONTAINS: CEFPODOXIME PROXETIL IP 200MG, COLOUR:TITANIUM DIOXIDE IP |
| 32 |  | C-FODE-CL TAB (MONO-ALU) | 6'S | EACH FILM COATED TABLET CONTAINS: CEFPODOXIME PROXITIL 200MG, CLAV 125MG, EXCIPIENTS Q.S, |
| 33 |  | CLARIFOD®-500 TAB (BL) | 10'S | EACH FILM COATED TABLET CONTAINS: CLARITHROMYCIN IP 500 MG, EXCIPENTS Q.S, COLOUR: LAKE QUINOLINE YELLOW & TITANIUM DIOXIDE IP |
| 34 |  | MOXIFLOT-400 TAB (BL-MONO) | 5'S | EACH FILM COATED TABLET CONTAINS: MOXIFLOXAXIN 400MG. |
| 35 |  | MOXINCLAV-625 TABS (20) | 6'S | EACH FILM COATED TABLET CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 500MG, POTASSIUM CLAVULANATE DILUTED IP EQ. TO CLAVULANIC ACID 125MG, EXCIPIENTS Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 36 |  | OFOXO® -200 TAB (M.P) | 10'S | EACH FILM COATED TABLET CONTAINS: OFLOXACIN 200MG, EXCIPIENTS Q.S, |
| 37 |  | OFOXO®-OZ TAB (BL) | 10'S | EACH FILM COATED TABLET CONTAINS: OFLOXACIN IP 200MG, ORNIDAZOLE IP 500MG, COLOURS: SUNSET YELLOW FCF |
| 38 |  | CHLORONOL-500 CAPSULES | 10 S | EACH HARD GELATIN CAPSULE CONTAINS: CHLORAMPHENICOL IP 500MG, APPROVED COLOURS USED IN EMPTY CAPSULE SHELLS. |
| 39 | | MOXIN-250 CAP (G/Y) 30'S | 10'S | EACH HARD GELATIN CAPSULE CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ.TO AMOXYCILLIN 250MG, EXCIPIENTS Q.S, COLOUR: TITANIUM DIOXIDE, CARMOISINE, PANCEAU 4R, SUNSET YELLOW. |
| 40 | | MOXIN-500 CAP (YELLOW) | 10'S | EACH HARD GELATIN CAPSULE CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 500MG, EXCIPIENTS Q.S, |
| 41 |  | N S IV | 100ML | EACH 100 ML CONTAINS: SODIUM CHLORIDE IP 0.9 GM, WATER FOR INJECTIONS IP Q.S. CONCENTRATION OF IONS. |
| 42 |  | OFOXO®-MZ SUSP (MONO) | 30ML | EACH 5 ML CONTAINS: OFLOXACIN IP 50MG, METRONIDAZOLE BENZOATE IP EQ. TO METRONIDAZOLE 120MG, SIMETHICONE IP 10MG, FLAVOURED SYRUPY BASE Q.S, COLOUR: QUINOLINE YELLOW WS |
| 43 | | CEFAXIME-O DRY SYP (PET) | 30ML | EACH 5ML OF RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME TRIHYDRATE 50MG |
| 44 |  | C-FODE DRY SYP (PET) | 30ML | EACH 5ML OF RECONSTITUTED SUSP.CONTAINS:CEFPODOXIME 50MG |
| 45 |  | M-CLAV D/S (PET) 30ML | 30ML | EACH 5 ML OF RECONSTITUTED SUSPENSION CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 200 MG, POTASSIUM CLAVULANTE DILUTED IP EQ. TO CLAVULANIC ACID 28.5 MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 46 |  | IMITIN® 1GM INJ | 500MG | EACH VIAL CONTAINS: IMIPENEM (STERILE) I.P. EQ. TO ANHYDROUS IMIPENEM 500MG, CILASTATIN SODIUM 9STERILE) I.P. EQ. TO CILASTATIN 500MG,SODIUM BICARBONATE I.P. ADDED AS BUFFER |
| 47 |  | TRAXONOL-1000 INJ. 1000MG | 1000MG | EACH VIAL CONTAIN: CEFTRIAXONE SODIUM IP (STERILE) + EQUIVALENT TO + ANHYDROUS CEFTRIAXONE 1000MG |
| 48 |  | TRAXONOL-S-1500 INJ | 1.5GM | EACH VIAL CONTAINS: CEFTRIAXONE SODIUM IP 1000MG. SULBACTAM SODIUM USP 500MG. |
| 49 |  | TRAXONOL-T INJ 1.125MG | 1.125MG | EACH VAIL CONTAINS: CEFTRIAXONE 1GM, TAZOBACTUM SODIUM 125MG |
| 50 |  | AZINOL 100 SUSP. (MONO) | | EACH 5ML CONTAINS: AZITHROMYCIN DIHYDRATE I.P. EQ. TO AZITHROMYCIN (ANHYDROUS) 100MG, FLAVOURED SYRUPY BASE Q.S, COLOUR: QUINOLINE YELLOW |
| 51 |  | AZINOL 200 SUSP. (MONO) | | EACH 5ML CONTAINS: AZITHROMYCIN DIHYDRATE I.P. EQ. TO AZITHROMYCIN (ANHYDROUS) 200MG, FLAVOURED SYRUPY BASE Q.S, COLOUR: QUINOLINE YELLOW |
| 52 |  | MOXINCLAV-CV (MONO) | | EACH FILM COATED TABLET CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQUIVALENT TO AMOXYCILLIN 500MG, POTASSIUM CLAVULANATE DILUTED IP EQUIVALENT TO CLAVULANIC ACID 125MG, EXCIIENTS Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 53 |  | CIFIZA-O 200 DT (ALU-MONO) | | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: CEFIXIME IP (AS TRIHYDRATE) EQ. TO ANHYDROUS CEFIXIME 200MG, EXCIPIENTS Q.S, |
| 54 |  | OFOXO®-M SUSP (MONO) | | EACH 5ML CONTAINS: OFLOXACIN I.P 50MG, METRONIDAZOLE BENZOATE I.P. EQ. TO METRONIDAZOLE 120MG, SIMETHICONE IP 10MG, IN A FLAVOURED PALATABLE BASE Q.S, COLOUR: SUNSET YELLOW FCF. |
| 55 |  | CEPDONOL-CV (GLASS BOTTLE WITH WATER) | | EACH 5ML CONTAINS: CEFPODOXIME 50MG, CLAVULANIC ACID 31.25MG/5ML |
| 56 |  | CIFIZA-O DRY SUSP. (GLASS BOTTLE, WITH WATER) | | EACH 5ML. OF THE RECONSTITUTED SUSPENSION CONTAINS: CEFIXIME IP EQUIVALENT TO ANHYDROUS CEFIXIME 50MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP. |
| 57 |  | KNOLLCLAV-CV DRY SYP (GLASS BOTTLE WITH WATER) | | EACH 5ML CONTAINS: AMOXICLAV THIHYDRATE 125MG, CLAUVLANIC 31.25MG, EXCIPIENTS Q.S, |
| 58 |  | METNIGYL IV | 100ML | EACH 100ML CONTAINS: METRONIDAZOLE IP 0.500MG, SODIUM CHLORIDE IP 0.8% W/V, WATER FOR INJECTION IP Q.S. |
| 59 | | MOXIN-250 DT TAB (BL) | 10'S | EACH UNCOTED TABLET CONTAINS: AMOXYCILLIN 250MG, EXCIPIENTS Q.S, |
| 60 | | MOXINCLAV-625 TAB (MONO-ALU) | 6'S | EACH FILM COATED TABLET CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 500MG, POTASSIUM CLAVULANATE DILUTED IP EQ. TO CLAVULANIC ACID 125MG, EXCIPIENTS Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 61 | | MOXINCLAV DRY SYP (GLASS) | 30ML | EACH 5 ML OF RECONSTITUTED SUSPENSION CONTAINS: AMOXYCILLIN TRIHYDRATE IP EQ. TO AMOXYCILLIN 200 MG, POTASSIUM CLAVULANTE DILUTED IP EQ. TO CLAVULANIC ACID 28.5 MG, IN A PALATABLE SUSPENSION BASE Q.S, COLOUR: TITANIUM DIOXIDE IP |
| 62 |  | LEVOKIN-500 TAB (BL-MONO) | 5'S | EACH FILM COATED TABLET CONTAINS: LEVOFLOXACIN 500MG, EXCIPIENTS Q.S, |
| 63 |  | VALCOVEER 1000 TAB | | EACH FILM COATED TABLET CONTAINS: VALACYCLOVIR HYDROCHLORIDE USP EQ. TO VALACYCLOVIR 1000MG, EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP. |
| 64 |  | VALCOVEER 500 TAB | | EACH FILM COATED TABLET CONTAINS: VALACYCLOVIR HYDROCHLORIDE USP EQ. TO VALACYCLOVIR 500MG, EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP. |
